Articles 

July, 2022          

 

Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study

 

By Einar Stefansson et al. Published by Acta Ophthalmologica

July, 2022          

 

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease

 

By Lee Shettle et al., Published by Clinical Ophthalmology

April, 2022          

 

2023 Will Be Pivotal Year for Oculis’ Potentially Transformative Medicines

 

By Gail Dutton in Biospace

December, 2021

 

The Diabetic Eye Disease Pipeline in 2021

 

By Xuejing Chen, Arshad M. Khanani and Caroline R. Baumal, in Retina Today

 

December, 2021          

 

Topical drug delivery to the retina: obstacles and routes to success

 

By Thorsteinn Loftsson, published by Expert Opinion on Drug Delivery

May, 2021

 

Ocular Surface Disease Product Roundup: The players you need to know

 

Editorial Spotlight (several authors) on CRST – Cataract and Refractive Surgery Today

April, 2021

 

Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment

 

By Thorsteinn Loftsson and Einar Stefansson, published by Acta Ophthalmologica

April, 2021

 

The quest for topical treatments for the posterior segment

 

By Dr Ramin Tadayoni on Ophthalmology Times Europe